Showing results (1511-1520 of 1,562) with videos related to
Sort By:
Pageof 157
Frontiers in Immunology|January 1, 2025
Clinical characteristics and prognostic factors of COVID-19 in rheumatic patients and their family members: a retrospective studyYihua Fan, Yiwen Wang, Juanli Du, et al.Science Immunology|November 4, 2018
Combination cancer immunotherapy targeting PD-1 and GITR can rescue CD8Bei Wang, Wen Zhang, Vladimir Jankovic, et al.Frontiers in Neurology|August 22, 2022
Deep learning-based relapse prediction of neuromyelitis optica spectrum disorder with anti-aquaporin-4 antibodyLiang Wang, Lei Du, Qinying Li, et al.Frontiers in Immunology|April 18, 2022
Neuromyelitis Optica Spectrum Disorder With Anti-Aquaporin-4 Antibody: Outcome Prediction ModelsLiang Wang, Lei Du, Qinying Li, et al.NPJ Vaccines|October 26, 2021
Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in SingaporeBei Wang, Yun Shan Goh, Tessa Prince, et al.Cell|October 20, 2018
Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver CancerVishal Singh, Beng San Yeoh, Benoit Chassaing, et al.Scientific Reports|May 5, 2026
Optimizing mouse models for mRNA vaccines: addressing dose translation challengesZi Wei Chang, Yong Jie Tan, Yiyu Liao, et al.CNS Drugs|October 23, 2025
Efficacy and Safety of Solriamfetol on Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea in China: A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical TrialHanrong Cheng, Liying Deng, Zili Meng, et al.Chinese Medical Journal|July 18, 2012
Elevated nocturnal and morning blood pressure in patients with obstructive sleep apnea syndromeQuan-Ying He, Jing Feng, Xi-Long Zhang, et al.Ebiomedicine|September 13, 2024
Potential immunomodulatory effects of CAS+IMD monoclonal antibody cocktail in hospitalized patients with COVID-19Bei Wang, Jacquelynn Golubov, Erin M Oswald, et al.Pageof 157